Pietenpol JA - Search Results

1

Clinical implications of molecular heterogeneity in triple negative breast cancer.

Lehmann BD, Pietenpol JA. Lehmann BD, et al. Among authors: pietenpol ja. Breast. 2015 Nov;24 Suppl 2(0 2):S36-40. doi: 10.1016/j.breast.2015.07.009. Epub 2015 Aug 5. Breast. 2015. PMID: 26253813 Free PMC article. Review.

2

A pilot study of neoadjuvant paclitaxel and radiation with correlative molecular studies in stage II/III breast cancer.

Chakravarthy A, Nicholson B, Kelley M, Beauchamp D, Johnson D, Frexes-Steed M, Simpson J, Shyr Y, Pietenpol J. Chakravarthy A, et al. Clin Breast Cancer. 2000 Apr;1(1):68-71. doi: 10.3816/CBC.2000.n.007. Clin Breast Cancer. 2000. PMID: 11899393

3

Combined modality management of breast cancer: development of predictive markers through proteomics.

Chakravarthy B, Pietenpol JA. Chakravarthy B, et al. Among authors: pietenpol ja. Semin Oncol. 2003 Aug;30(4 Suppl 9):23-36. doi: 10.1016/s0093-7754(03)00267-7. Semin Oncol. 2003. PMID: 12908134 Review.

4

RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells.

Bauer JA, Ye F, Marshall CB, Lehmann BD, Pendleton CS, Shyr Y, Arteaga CL, Pietenpol JA. Bauer JA, et al. Among authors: pietenpol ja. Breast Cancer Res. 2010;12(3):R41. doi: 10.1186/bcr2595. Epub 2010 Jun 24. Breast Cancer Res. 2010. PMID: 20576088 Free PMC article.

5

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.

Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA. Lehmann BD, et al. Among authors: pietenpol ja. J Clin Invest. 2011 Jul;121(7):2750-67. doi: 10.1172/JCI45014. J Clin Invest. 2011. PMID: 21633166 Free PMC article.

6

TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer.

Chen X, Li J, Gray WH, Lehmann BD, Bauer JA, Shyr Y, Pietenpol JA. Chen X, et al. Among authors: pietenpol ja. Cancer Inform. 2012;11:147-56. doi: 10.4137/CIN.S9983. Epub 2012 Jul 24. Cancer Inform. 2012. PMID: 22872785 Free PMC article.

7

Targeting mutant p53 in human tumors.

Lehmann BD, Pietenpol JA. Lehmann BD, et al. Among authors: pietenpol ja. J Clin Oncol. 2012 Oct 10;30(29):3648-50. doi: 10.1200/JCO.2012.44.0412. Epub 2012 Sep 10. J Clin Oncol. 2012. PMID: 22965952 Review. No abstract available.

8

Patient-derived breast tumor xenografts facilitating personalized cancer therapy.

Landis MD, Lehmann BD, Pietenpol JA, Chang JC. Landis MD, et al. Among authors: pietenpol ja. Breast Cancer Res. 2013 Jan 22;15(1):201. doi: 10.1186/bcr3355. Breast Cancer Res. 2013. PMID: 23339383 Free PMC article. Review.

9

Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breast cancer.

Yu KD, Zhu R, Zhan M, Rodriguez AA, Yang W, Wong S, Makris A, Lehmann BD, Chen X, Mayer I, Pietenpol JA, Shao ZM, Symmans WF, Chang JC. Yu KD, et al. Among authors: pietenpol ja. Clin Cancer Res. 2013 May 15;19(10):2723-33. doi: 10.1158/1078-0432.CCR-12-2986. Epub 2013 Apr 2. Clin Cancer Res. 2013. PMID: 23549873 Free PMC article.

10

Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes.

Masuda H, Baggerly KA, Wang Y, Zhang Y, Gonzalez-Angulo AM, Meric-Bernstam F, Valero V, Lehmann BD, Pietenpol JA, Hortobagyi GN, Symmans WF, Ueno NT. Masuda H, et al. Among authors: pietenpol ja. Clin Cancer Res. 2013 Oct 1;19(19):5533-40. doi: 10.1158/1078-0432.CCR-13-0799. Epub 2013 Aug 15. Clin Cancer Res. 2013. PMID: 23948975 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters